Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Nucleolar | 2 | 2024 | 4 | 0.900 |
Why?
|
| MicroRNAs | 3 | 2023 | 518 | 0.780 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 1723 | 0.420 |
Why?
|
| Neoplasms | 1 | 2024 | 1377 | 0.380 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 704 | 0.310 |
Why?
|
| Lipids | 2 | 2020 | 256 | 0.290 |
Why?
|
| Carboxylic Ester Hydrolases | 2 | 2017 | 58 | 0.240 |
Why?
|
| Cell Nucleolus | 1 | 2024 | 11 | 0.210 |
Why?
|
| RNA, Ribosomal | 1 | 2024 | 31 | 0.210 |
Why?
|
| Ribosomes | 1 | 2024 | 35 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 133 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 81 | 0.190 |
Why?
|
| Prostatic Neoplasms | 2 | 2023 | 1092 | 0.180 |
Why?
|
| Exosomes | 1 | 2023 | 126 | 0.180 |
Why?
|
| Osteoarthritis | 1 | 2021 | 25 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 384 | 0.170 |
Why?
|
| Proteomics | 1 | 2023 | 378 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 122 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 495 | 0.150 |
Why?
|
| Muscle Development | 2 | 2017 | 51 | 0.140 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 247 | 0.140 |
Why?
|
| Heart Failure | 1 | 2021 | 302 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2017 | 12 | 0.130 |
Why?
|
| Humans | 9 | 2024 | 43102 | 0.130 |
Why?
|
| Stroke | 1 | 2021 | 340 | 0.130 |
Why?
|
| Integrins | 1 | 2017 | 54 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 118 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 539 | 0.120 |
Why?
|
| NF-kappa B | 2 | 2023 | 358 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 316 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2015 | 638 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2011 | 44 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 164 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 183 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 183 | 0.080 |
Why?
|
| Female | 3 | 2024 | 24698 | 0.070 |
Why?
|
| Aging | 1 | 2011 | 783 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2017 | 70 | 0.060 |
Why?
|
| Aged | 3 | 2024 | 8214 | 0.060 |
Why?
|
| Hemolysis | 1 | 2023 | 60 | 0.050 |
Why?
|
| Fasting | 1 | 2023 | 56 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2023 | 49 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2024 | 144 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2023 | 272 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 115 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 1035 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2023 | 165 | 0.050 |
Why?
|
| Prognosis | 1 | 2024 | 861 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 239 | 0.040 |
Why?
|
| Computational Biology | 1 | 2023 | 327 | 0.040 |
Why?
|
| Male | 4 | 2024 | 23409 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 1600 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2024 | 1604 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 74 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 1759 | 0.040 |
Why?
|
| Animals | 4 | 2023 | 16992 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2023 | 2157 | 0.040 |
Why?
|
| Mice | 2 | 2023 | 6644 | 0.040 |
Why?
|
| Macrophages | 1 | 2023 | 529 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 968 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 570 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 332 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 2853 | 0.030 |
Why?
|
| Sarcolemma | 1 | 2017 | 4 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2017 | 8 | 0.030 |
Why?
|
| Dystrophin | 1 | 2017 | 20 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 12222 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 30 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 300 | 0.030 |
Why?
|
| Hawaii | 1 | 2021 | 2011 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 189 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2544 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 227 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 152 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 532 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 3994 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 436 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2011 | 20 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2011 | 36 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 712 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 98 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 1410 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 462 | 0.020 |
Why?
|
| United States | 1 | 2021 | 5205 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1869 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 263 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 1621 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1568 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 1177 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 1766 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 3735 | 0.010 |
Why?
|